| VIR Snapshot | |
|---|---|
| Vir Biotechnology, Inc., a clinical-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. The company is headquartered in San Francisco, California. | |
| VALUATION DATA | |
| Market Capitalization | $3,224,679,000 | Price to Sales | 1.39 |
| Earnings per Share | $8.9900 |
| PE Ratio | 2.709 |
| PRICE DATA | |
| Most Recent Close | $24.1400 |
| 52 Week High | $58 |
| 52 Week Low | $18.21 |
| 50-Day Moving Average | $22.86 |
| 200-Day Moving Average | $34.78 |
| All data are from Alpha Vantage as of today. For more infomation on VIR see Stock Dividend, Valuation, Price and Financial Data for Investors | |
Custom Search